AAAS and Science Translational Medicine invite applications for the 2014 AAAS Martin and Rose Wachtel Cancer Research Award. This annual award, funded by an endowment established through a generous bequest from Martin L. Wachtel, will honor an early-career investigator who has performed outstanding work in the field of cancer research. Entrants must have received their Ph.D. or M.D. within the last 10 years. The award winner will be invited to deliver a public lecture on his or her research and will receive a cash award of $25,000. The award winner's Essay will be published as a Perspective in Science Translational Medicine.
The deadline for application is 1 March 2014.
Entry packages must include the following materials, written in English:
Send all materials in the entry package in pdf format to Katrina Kelner, Editor Science Translational Medicine at email@example.com  with Wachtel Award Entry in the subject line. Please note: If your contact information changes after submission then you must inform us at firstname.lastname@example.org .
The editors of Science Translational Medicine will be responsible for the initial evaluation of the Essays. Approximately the top 10 percent of the Essays will be forwarded to the judging panel. The judging panel is composed of prominent international researchers in the field of cancer and will include Phillip A. Sharp, President of the AAAS Board of Directors. The applicants will be rated on two characteristics: scientific quality and significance of their research, and the clarity and style of the Essay.
Send inquiries by email to email@example.com .
AAAS AND SCIENCE TRANSLATIONAL MEDICINE ANNOUNCE THE WINNER OF THE INAUGURAL AAAS MARTIN AND ROSE WACHTEL CANCER RESEARCH AWARD.
The winner of the inaugural AAAS Martin and Rose Wachtel Cancer Research Award in 2013 was Dr. Scott A. Tomlins, an Assistant Professor in the Michigan Center for Translational Pathology at the University of Michigan Medical School.
The 3 runners up were: Gregory Beatty, University of Pennsylvania School of Medicine; Michele De Palma, Swiss Federal Institute of Technology Lausanne; and Franziska Michor, Dana Farber Cancer Institute.